Icosavax, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2017-01-01
- Employees
- 60
- Market Cap
- -
- Website
- http://www.icosavax.com
Clinical Trials
5
Active:1
Completed:4
Trial Phases
2 Phases
Phase 1:2
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (60.0%)Phase 1
2 (40.0%)A Study of IVX-A12 in Adults Participants
Phase 2
Completed
- Conditions
- Healthy Participants
- Interventions
- Biological: Licensed RSV Vaccine
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Icosavax, Inc.
- Target Recruit Count
- 143
- Registration Number
- NCT06481579
- Locations
- 🇺🇸
Icosavax Investigational Site US022, Anaheim, California, United States
🇺🇸Icosavax Investigational Site US021, Rolling Hills Estates, California, United States
🇺🇸Icosavax Investigational Site US002, Hollywood, Florida, United States
A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age
Phase 2
Active, not recruiting
- Conditions
- Healthy
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Icosavax, Inc.
- Target Recruit Count
- 264
- Registration Number
- NCT05903183
- Locations
- 🇺🇸
AMR Phoenix, Tempe, Arizona, United States
🇺🇸Cenexel RCA, Hollywood, Florida, United States
🇺🇸Clinical Research Atlanta, Stockbridge, Georgia, United States
Safety and Immunogenicity of IVX-A12 in Healthy Older Adults
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Icosavax, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT05664334
- Locations
- 🇺🇸
CenExcel RCA, Hollywood, Florida, United States
🇺🇸CenExcel ACMR, Atlanta, Georgia, United States
🇺🇸Meridien Clinical Research, Omaha, Nebraska, United States
News
No news found